REFERENCES
- Han Y, Wind-Rotolo M, Yang HC, et al. Experimental approaches to the study of HIV-1 latency. Nat Rev Microbiol. 2007; 5: 95–106.
- Persaud D, Pierson T, Ruff C, et al. A stable latent reser-voir for HIV-1 in resting CD4(+) T lymphocytes in infected chil-dren. J Clin Invest. 2000; 105: 995–1003.
- Ruff CT, Ray SC, Kwon P, et al. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure. J Virol. 2002; 76: 9481-9492.
- Katlama C, Fenske S, Gazzard B, et al. TRIZAL study: switching from successful HAART to Trizivir (abacavir-lamivu-dine-zidovudine combination tablet): 48 weeks efficacy, safety and adherence results. HIV Med. 2003; 4: 79–86.
- Opravil M, Hirschel B, Lazzarin A, et al. A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection. J In-fect Dis. 2002; 185: 1251–1260.
- Mastroianni CM, d'Ettorre G, Vullo V. Evolving simplified treatment strategies for HIV infection: the role of a single-class quadruple-nucleoside/nucleotide regimen of trizivir and tenofovir. Expert Opin Pharmacother. 2006; 7: 2233-2241.
- d'Ettorre G, Zaffiri L, Ceccarelli G, et al. Simplified main-tenance therapy with abacavir/lamivudine/zidovudine plus teno-fovir after sustained HIV load suppression: four years of follow-up. HIV Clin Trials. 2007; 8: 182–8.
- Martinez E, Arnaiz JA, Podzamczer D, et al. Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in Patients with human immunodeficiency virus infection. N Engl J Med. 2003; 349: 1036–1046.
- Opravil M, Baumann D, Chave JP, et al. Long-term effi-cacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine. AIDS. 2004; 18: 2213–2215.
- Parikh UM, Zelina S, Sluis-Cremer N, et al. Molecular mechanisms of bidirectional antagonism between K65R and thymidine analog mutations in HIV-1 reverse transcriptase. AIDS. 2007; 21: 1405-1414.